Regency Centers Reports Strong Q4 & Full Year 2025 Results, Raises Dividend, Provides Positive 2026 FFO Guidance
summarizeSummary
Regency Centers reported robust fourth quarter and full year 2025 financial and operating results, including significant FFO and NOI growth, and increased its quarterly common stock dividend. The company also provided initial 2026 guidance, projecting continued FFO and Core Operating Earnings growth.
check_boxKey Events
-
Strong 2025 Financial Performance
Reported full-year Nareit FFO of $4.64 per diluted share and Core Operating Earnings of $4.41 per diluted share, representing 7.9% and 6.8% growth, respectively.
-
Increased Quarterly Dividend
The Board declared a quarterly cash dividend of $0.755 per common share, payable April 1, 2026, an increase from the prior quarter.
-
Positive 2026 FFO Guidance
Initial 2026 guidance projects Nareit FFO per diluted share of $4.83 - $4.87 and Core Operating Earnings per diluted share of $4.59 - $4.63, indicating continued growth.
-
Decelerating Same Property NOI Growth
Same Property NOI growth without termination fees is guided to +3.25% to +3.75% for 2026, a deceleration from the 5.3% achieved in 2025.
auto_awesomeAnalysis
Regency Centers delivered strong performance in 2025, exceeding prior year figures across key metrics like Nareit FFO, Core Operating Earnings, and Same Property Net Operating Income. The increase in the quarterly common stock dividend signals confidence in future cash flows. While the 2026 guidance projects continued growth in FFO and Core Operating Earnings, the anticipated slowdown in Same Property NOI growth and the planned pause in acquisitions and dispositions for 2026 suggest a shift towards internal growth and development projects. Investors should monitor the execution of the $597 million in-process development pipeline and the impact of the decelerating NOI growth on future performance.
At the time of this filing, REG was trading at $75.48 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $13.6B. The 52-week trading range was $63.44 to $78.18. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.